associate director clinical research early phase oncology @ Merck
Holly Hirschkorn
GET FULL PROFILE 
Real-Time AI Research
FlashIntel GPT
Tell me more about Holly Hirschkorn?
FlashIntel GPTHolly Hirschkorn is a Clinical Team Lead at Covance, a research services company based in Princeton, New Jersey. With a strong background in clinical research, Holly has gained valuable experience in leading clinical teams and ensuring the success of the company. Currently based in Brentwood, Tennessee, Holly brings her expertise and leadership skills to the Other department at Covance. With a team of 5001-10000 staff members, Covance focuses on providing professional and technical research services.
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
Work Experience
associate director clinical research early phase oncology
Pharmaceutical Manufacturing
Holly Hirschkorn's Professional Milestones
- Clinical Team Lead: Supervised team efforts to deliver exceptional patient care and maintain high standards of quality.
- associate director clinical research early phase oncology : Expanding therapeutic options and providing crucial support to the advancement of early phase cancer in the oncology field.
Certification
Colleagues
Shawn S.
biologist at merck game developer business owner
Ryan Watt
Product Owner
Pascale Schoofs
medical advisor at schering plough and owner schoofs medical interim management: smim
Patrizia Favini
Owner
Tom McCallister
sap business process owner at jacklinks
Other Named Holly Hirschkorn
Frequently asked questions
We found 5 Holly Hirschkorn's email addresses
We found 1 Holly Hirschkorn's phone numbers
Holly Hirschkorn's social media include: Linkedin,
Holly Hirschkorn works for Merck
Holly Hirschkorn's role in Merck is associate director clinical research early phase oncology
Holly Hirschkorn works in the industry of Pharmaceutical Manufacturing
Holly Hirschkorn's colleagues are Shawn S.,Ryan Watt,Pascale Schoofs
Holly Hirschkorn's latest job experience is associate director clinical research early phase oncology at Merck
